FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34166411000001105: Imatinib 100mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103592301000001117 Imatinib 100mg tablets (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103592401000001113 Imatinib 100mg tablets (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imatinib 100mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Is a Imatinib 100mg tablets true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Is a Imatinib 100mg tablets false Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Is a Product containing precisely imatinib 100 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has active ingredient Imatinib false Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has specific active ingredient Imatinib mesilate true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imatinib true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Imatinib 100mg tablets (Sandoz Ltd) Has basis of strength substance Imatinib true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Imatinib 100mg tablets (Sandoz Ltd) 60 tablet 6 x 10 tablets Has AMP True Imatinib 100mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start